Talha Munir

Talha Munir

St. James’s University Hospital, Leeds, UK

Dr Talha Munir is a Consultant Haematologist at Leeds Teaching Hospitals NHS Trust. He graduated in 2002 from King Edward Medical College, Lahore, Pakistan, and finished his initial training in Pakistan. Talha has worked in the NHS since 2004 and completed his haematology training in Nottingham, in 2012.

Talha’s main clinical and research interests are in CLL, particularly in the assessment of the mechanism of action of novel targeted therapies. He attained PhD from University of Leeds in 2022 and his research explored the effect of B-cell receptor inhibitors on the phosphorylation marks in the B-cell receptor pathway.

 His other clinical interests include the management of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria (PNH), and he is one of the PNH consultants working in the PNH National Service, Leeds. Talha also has a special interest in the management of adult histiocytic disorders, especially Langerhans’ cell histiocytosis (LCH) and Erdheim–Chester disease.

He is a sub-investigator for the NCRI CLL phase II and III clinical trials in the UK and is involved in multiple NCRI and non-NCRI studies at Leeds Teaching Hospitals, where he has contributed to the development of an impressive trial portfolio.

Back to speakers